Mankind Pharma Limited Mankind Pharma Limited

Mankind Pharma Limited

MANKIND

Rang in Aktien #2064
Mankind Pharma Limited specializes in the development, manufacturing, and... Mankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.
Aktienkurs
$24.08
Marktkapitalisierung
$9.95B
Veränderung (1 Tag)
-4.09%
Veränderung (1 Jahr)
-13.33%
Land
IN
Handel Mankind Pharma Limited (MANKIND)

Kategorie

Healthcare
Operative Marge für Mankind Pharma Limited (MANKIND)
Operative Marge zum October 2026 TTM: 19.91%
Laut den neuesten Finanzberichten und dem Aktienkurs von Mankind Pharma Limited beträgt die aktuelle operative Marge (TTM) 19.91%. Am Ende des Jahres 2025 lag die operative Marge bei 20.61%.
Historie der operativen Marge von Mankind Pharma Limited von 2019 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) 19.91% -3.40%
2025 20.61% -47.88%
2024 39.54% 113.61%
2023 18.51% -22.62%
2022 23.92% -7.47%
2021 25.85% 0.15%
2020 25.81% 47.82%
2019 17.46% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
19.41% -99.03%
DE
0.00% -
DE
10.52% -99.47%
JP
17.08% -99.14%
CH
22.93% -98.85%
IN
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.